Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LXRX | MNPR | LCTX | ||
| Company | Lexicon Pharmaceutcl | Monopar Therapeutics Inc | Lineage Cell Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 1.1500 | 64.05 | 1.8000 | ||
| High | 1.1800 | 66.19 | 1.8169 | ||
| Low | 1.1400 | 61.32 | 1.7500 | ||
| Latest | 1.1750 | 61.44 | 1.7650 | ||
| Change | +0.0050 | -3.57 | -0.0650 | ||
| % Change | +0.43% | -5.49% | -3.55% | ||
| Volume | 266,849 | 120,243 | 393,119 | ||
| 20-Day Average Volume | 1,581,241 | 298,578 | 1,193,179 | ||
| Previous Close | 1.1700 | 65.01 | 1.8300 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.1997 | 68.57 | 1.7036 | ||
| 20-Day Raw Stochastic | 25.95% | 24.61% | 71.92% | ||
| 20-Day Relative Strength | 42.55 | 38.35 | 53.04 | ||
| Weighted Alpha | +42.61 | +34.43 | +153.44 | ||
| Today's Opinion | 8% Sell | 8% Buy | 80% Buy | ||
| Previous Opinion | 8% Sell | 8% Buy | 80% Buy | ||
| Last Month's Opinion | 56% Buy | 48% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.17% since 12/31/25 | -5.28% since 12/31/25 | +5.51% since 12/31/25 | ||
| Low | 1.1100 on 01/02/26 | 56.15 on 01/06/26 | 1.6150 on 01/02/26 | ||
| High | 1.2300 on 01/07/26 | 70.01 on 01/02/26 | 1.8350 on 01/07/26 | ||
| 1-Month | |||||
| %Chg | -15.47% since 12/08/25 | -19.08% since 12/08/25 | +4.26% since 12/08/25 | ||
| Low | 1.1100 on 01/02/26 | 56.15 on 01/06/26 | 1.5750 on 12/30/25 | ||
| High | 1.4000 on 12/09/25 | 79.31 on 12/10/25 | 1.8350 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | -17.83% since 10/08/25 | -37.25% since 10/08/25 | +1.85% since 10/08/25 | ||
| Low | 1.1100 on 01/02/26 | 56.15 on 01/06/26 | 1.5300 on 11/07/25 | ||
| High | 1.6600 on 10/10/25 | 104.00 on 10/14/25 | 2.0900 on 11/03/25 | ||
| 6-Month | |||||
| %Chg | +28.19% since 07/08/25 | +61.19% since 07/08/25 | +78.90% since 07/08/25 | ||
| Low | 0.9078 on 07/09/25 | 29.18 on 08/26/25 | 0.9296 on 07/22/25 | ||
| High | 1.6600 on 10/10/25 | 105.00 on 10/06/25 | 2.0900 on 11/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 425,177 | 434,436 | 421,500 | ||
| Shares Outstanding, K | 363,399 | 6,683 | 230,328 | ||
| Annual Sales | 31,080,000 | 0 | 9,500,000 | ||
| Annual Net Income | -200,400,000 | -15,590,000 | -18,610,000 | ||
| Last Quarter Sales | 14,180,000 | 0 | 3,680,000 | ||
| Last Quarter Net Income | -12,770,000 | -3,440,000 | -29,780,000 | ||
| 60-Month Beta | 0.71 | 1.46 | 1.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 11/06/25 | -0.48 on 11/13/25 | -0.13 on 11/06/25 | ||
| Latest Earnings Date | 03/05/26 | 03/30/26 | 03/09/26 | ||
| Most Recent Dividend | N/A | N/A | 0.080 on 12/15/03 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||